As of Jun 24
| -1.47 / -5.91%|
The 8 analysts offering 12-month price forecasts for AMAG Pharmaceuticals Inc have a median target of 38.50, with a high estimate of 80.00 and a low estimate of 27.00. The median estimate represents a +64.39% increase from the last price of 23.42.
The current consensus among 9 polled investment analysts is to Buy stock in AMAG Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.